Live Breaking News & Updates on Protara Therapeutics Company Profile

Stay updated with breaking news from Protara therapeutics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Protara Therapeutics, Inc. (NASDAQ:TARA) Major Shareholder Sells $100,980.00 in Stock

Protara Therapeutics, Inc. (NASDAQ:TARA – Get Free Report) major shareholder Opaleye Management Inc. sold 33,000 shares of the stock in a transaction dated Tuesday, May 21st. The shares were sold at an average price of $3.06, for a total transaction of $100,980.00. Following the sale, the insider now directly owns 124,250 shares of the company’s […] ....

Opaleye Management Inc , Exchange Commission , Ikarian Capital , Securities Exchange Commission , Protara Therapeutics Company Profile , Protara Therapeutics Inc , Protara Therapeutics , Get Free Report , Opaleye Management , Free Report , Protara Therapeutics Daily ,

Protara Therapeutics, Inc. (NASDAQ:TARA) Short Interest Up 158.6% in April

Protara Therapeutics, Inc. (NASDAQ:TARA) Short Interest Up 158.6% in April
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Protara Therapeutics Inc , Oppenheimer Co , Protara Therapeutics Company Profile , Exchange Commission , Opaleye Management Inc , Protara Therapeutics , Get Free Report , Opaleye Management , Free Report , Protara Therapeutics Daily ,

Short Interest in Protara Therapeutics, Inc. (NASDAQ:TARA) Rises By 510.9%

Protara Therapeutics, Inc. (NASDAQ:TARA – Get Free Report) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totalling 398,300 shares, a growth of 510.9% from the March 31st total of 65,200 shares. Approximately 4.4% of the shares of the company are short sold. Based […] ....

Protara Therapeutics Company Profile , Protara Therapeutics Inc , Protara Therapeutics , Get Free Report , Protara Therapeutics Daily ,

Protara Therapeutics, Inc. (NASDAQ:TARA) Short Interest Update

Protara Therapeutics, Inc. (NASDAQ:TARA – Get Free Report) was the recipient of a large drop in short interest during the month of July. As of July 31st, there was short interest totalling 77,700 shares, a drop of 28.5% from the July 15th total of 108,600 shares. Based on an average daily trading volume, of 34,000 […] ....

Virtu Financial , Protara Therapeutics Inc , Privium Fund Management United Kingdom Ltd , Protara Therapeutics Company Profile , Renaissance Technologies , Privium Fund Management , Protara Therapeutics , Get Free Report , Fund Management United Kingdom Ltd , Protara Therapeutics Daily , Nasdaq Tara ,

Opaleye Management Inc. Cuts Stock Holdings in ProQR Therapeutics (NASDAQ:PRQR)

Opaleye Management Inc. decreased its stake in Protara Therapeutics, Inc. (NASDAQ:TARA – Get Rating) by 0.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,692,594 shares of the company’s stock after selling 15,473 shares during the period. Protara Therapeutics comprises about 2.5% of […] ....

Opaleye Management Inc , Protara Therapeutics Inc , Privium Fund Management United Kingdom Ltd , Protara Therapeutics Company Profile , Virtu Financial , Exchange Commission , Renaissance Technologies , Opaleye Management , Protara Therapeutics , Get Rating , Fund Management United Kingdom Ltd , Therapeutics Trading Down , Visit Holdingschannel , Protara Therapeutics Daily ,